Stockscreener 앱 받기
0.7142
3.48%
0.024
시간 외 거래:
.67
-0.0442
-6.19%
전일 마감가:
$0.6902
열려 있는:
$0.801
하루 거래량:
678.32K
Relative Volume:
0.10
시가총액:
$7.52M
수익:
$6.92M
순이익/손실:
$-32.03M
주가수익비율:
-0.1318
EPS:
-5.4201
순현금흐름:
$-22.13M
1주 성능:
-3.47%
1개월 성능:
-25.69%
6개월 성능:
-70.61%
1년 성능:
+185.57%
1일 변동 폭
$0.6951
$0.801
1주일 범위
$0.6666
$0.801
52주 변동 폭
$0.1521
$4.78
Beyond Air Inc Stock (XAIR) Company Profile
명칭
Beyond Air Inc
전화
516-665-8200
주소
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.7142 | 7.27M | 6.92M | -32.03M | -22.13M | -5.4201 |
ABT
Abbott Laboratories
|
102.38 | 178.41B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
329.40 | 125.84B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.06 | 111.25B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.00 | 93.26B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.26 | 46.17B | 6.07B | 1.06B | 1.34B | 1.8063 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-17 | 개시 | D. Boral Capital | Buy |
| 2024-06-25 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-07-28 | 개시 | Piper Sandler | Overweight |
| 2023-06-15 | 개시 | BTIG Research | Buy |
| 2021-04-28 | 개시 | Truist | Buy |
| 2019-10-22 | 개시 | Oppenheimer | Outperform |
모두보기
Beyond Air Inc 주식(XAIR)의 최신 뉴스
Beyond Air Names Robert Goodman as New CEO - TipRanks
Beyond Air's Steven A. Lisi resigns as CEO; Robert Goodman named CEO - tradingview.com
[8-K] Beyond Air, Inc. Reports Material Event - Stock Titan
Beyond Air secures GPO deal expanding hospital access to LungFit - Investing.com
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO) - manilatimes.net
Nearly 2,000 more hospitals can buy Beyond Air's tankless nitric oxide system - Stock Titan
Beyond Air CEO Steve Lisi resigns, Robert Goodman appointed successor - MSN
Fed Watch: Will Beyond Air Inc outperform the market in YEAR2026 Growth vs Value & Community Trade Idea Sharing - baoquankhu1.vn
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor By Investing.com - Investing.com Australia
XAIR Technical Analysis | Trend, Signals & Chart Patterns | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air stock sees CEO change as BTIG maintains Neutral rating - au.investing.com
Beyond Air stock sees CEO change as BTIG maintains Neutral rating By Investing.com - Investing.com South Africa
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO - Bitget
Beyond Air Names Robert Goodman, Chief Comml Officer, as CEO >XAIR - moomoo.com
Beyond Air CEO Steve Lisi resigns, Robert Goodman named successor - Investing.com
Beyond Air swaps CEOs as it pushes wider LungFit PH rollout - Stock Titan
Signal Recap: Is Beyond Air Inc showing insider buyingMarket Risk Report & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Earnings Risk: Will Beyond Air Inc stock benefit from M AWeekly Trade Recap & Low Risk Entry Point Guides - baoquankhu1.vn
Beyond Air appoints Duke Drewell as interim CFO - MSN
Form 8K Beyond Air Inc For: 15 January - Investing.com
XAIR Stock Price, Quote & Chart | BEYOND AIR INC (NASDAQ:XAIR) - ChartMill
Beyond Air, Inc. Trade Ideas — GETTEX:48L0 - TradingView
Beyond Air (XAIR) Retains 'Buy' Rating with $10 PT by D. Boral C - GuruFocus
Beyond Air (XAIR) Sees Promising Phase 1 Trial Results for Cance - GuruFocus
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial - The Manila Times
High-dose nitric oxide shot shows early activity in small cancer trial - Stock Titan
Beyond Air at Life Sciences Forum: Strategic Innovations in Medical Devices - Investing.com Canada
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR) - The Globe and Mail
XAIR: Second-generation nitric oxide system targets global growth and improved hospital adoption - TradingView
Beyond Air to Participate in the 38th Annual Roth Conference in March - The Manila Times
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals By Investing.com - Investing.com Canada
Beyond Air terminates NeuroNOS sale talks with XTL Biopharmaceuticals - Investing.com South Africa
XTL Biopharmaceuticals (NASDAQ: XTLB) NeuroNOS deal LOI expires with Beyond Air - Stock Titan
Beyond Air (XAIR) Buy Rating Reaffirmed by D. Boral Capital | XA - GuruFocus
Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - Bitget
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd. - The Manila Times
Beyond Air drops NeuroNOS sale, rethinks neurological and cancer plans - Stock Titan
XTL Biopharmaceuticals Ltd. cancelled the acquisition of 85% stake in NeuroNos Limited from Beyond Air, Inc.. - marketscreener.com
New Highs: Is Beyond Air Inc stock a falling knife or bargain buy2025 Biggest Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Technical Analysis: Can Beyond Air Inc continue delivering strong returns2025 Risk Factors & Verified Short-Term Trading Plans - baoquankhu1.vn
Insider Sell: Will Beyond Air Inc benefit from geopolitical trends2025 Short Interest & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Swing Trade: Is Beyond Air Inc stock a buy or sellWeekly Trading Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Beyond Air Inc (XAIR) Expands Focus on Nitric Oxide Therapies - Finviz
12 Best NASDAQ Penny Stocks to Buy According to Analysts - Insider Monkey
Published on: 2026-03-02 20:03:07 - baoquankhu1.vn
Bull Bear: Can Beyond Air Inc deliver consistent EPS growthJuly 2025 Setups & Stock Portfolio Risk Management - baoquankhu1.vn
XAIR Should I Buy - Intellectia AI
XAIR PE Ratio & Valuation, Is XAIR Overvalued - Intellectia AI
How The Narrative On Beyond Air (XAIR) Is Resetting Around LungFit PH And Delayed Approval - Yahoo Finance
Earnings Beat: What is the PEG ratio of Beyond Air IncJuly 2025 Final Week & Real-Time Chart Pattern Alerts - baoquankhu1.vn
XAIR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Beyond Air Inc (XAIR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.54%
자본화:
|
볼륨(24시간):